Universal Sequencing Technology and Shanghai Bioscience Form a Partnership for the Distribution of TELL-Seq™ Linked-Read NGS Library Prep Products
This distribution partnership will allow scientists in China to adopt the groundbreaking TELL-Seq™ Whole Genome Sequencing technology for their complex DNA sequencing projects
CANTON, Mass., Oct. 13, 2020 /PRNewswire-PRWeb/ -- Universal Sequencing Technology Corporation ('UST'), a developer of Next Generation Sequencing (NGS) technologies, today is proud to announce a commercial relationship with Shanghai Bioscience Ltd. for the distribution of TELL-Seq WGS Library preparation kits in China.
The TELL-Seq kit allows customers to transform their short-read DNA sequencer into a long-read DNA sequencer. The method is very scalable and can be readily automated for large sequencing projects. Also, TELL-Seq removes the need for large quantities of sample DNA for important applications such as, de novo DNA sequencing as well as elucidating genomic structural variations and genome phasing.
Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454. The TELL-Seq WGS Library Preparation kit is the first product launched from UST with multiple products in the pipeline. The underlying technology behind the TELL-Seq, which stands for Transposase Enzyme Linked Long-read Sequencing, was invented by Chief Science Officer Zhoutao "Tom" Chen.
Shanghai Bioscience Ltd (Bioscience), established in 2005, was the first company in China focused on the sales of life science laboratory consumables. Bioscience supplies life science researchers with consumables, reagents, instruments, and related services throughout China
Bioscience General Manager, Weihao Jiang, said "We hope through a strong alliance with UST, we will be able to provide Chinese DNA sequencing users better library preparation products, so they can get their sequencing work done in a more accurate, more effective and more economical way, and more applications, promoting the Chinese life science research and sequencing industry to a new level."
"We are very excited to work with Shanghai Bioscience," stated Dr. Ming Lei, Universal Sequencing's CEO and co-founder. "They are well known throughout China as the premier distribution channel and we know they will get our groundbreaking technology into many research labs."
ABOUT UNIVERSAL SEQUENCING TECHNOLOGY
Universal Sequencing Technology was established by a group of NGS technology veterans. UST is dedicated to the development of the most advanced, cost-effective, long-read, DNA sequencing technologies. Currently, UST has filed a total of 25 provisional patent filings covering linked, long-read library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology. UST is poised to lead the next wave of DNA sequencing innovations.
ABOUT SHANGHAI BIOSCIENCE LTD
Shanghai Bioscience Ltd. (Bioscience), was founded to provide one-stop services for scientific researchers in China. Bioscience has formed strategic distribution partnerships with world renown corporations, such as Corning, Takara, Danaher, Cole-Parmer. Bioscience has branch offices/facilities in 20 major cities all over China with around 350 employees, including professional technical support team and highly experienced sales team.
For Universal Sequencing Technology Corp. Media Inquire
Name: Andrew Bond
Phone: 857-999-0988
Email: [email protected]
For Shanghai Bioscience Ltd. Media Inquiries
Name: Weihao Jiang
Phone: 139 0183 9532
Email: [email protected]
SOURCE Universal Sequencing
Share this article